Iodantinopyrin, tablets 100 mg 50 pcs

Pharmacodynamics.
Jodantipyrine has anti-inflammatory, immunostimulatory and interferonogenic properties. It stabilizes biological membranes and inhibits virus penetration into the cell. It is an active inducer of alpha and beta interferon, stimulates cellular and humoral immunity. It is active against tick-borne encephalitis virus, hemorrhagic fever with renal syndrome.

Pharmacokinetics.
Fastly absorbed from the gastrointestinal tract, bioavailability is 80%. Up to 95% is metabolized in the liver. Urinary excretion through the kidneys by active transport to the renal tubules: 3-5% unchanged, 80-90%) – inactive metabolites. It has high affinity to tissue proteins. Binding to blood proteins is 25%. The elimination half-life is about 6 hours.

Indications

Active ingredient

Composition

Active ingredients:Iodantipyrine – 0,1 g
Additional ingredients:potato starch, glucose, magnesium stearate, polyvinylpyrrolidone low molecular weight medical.

How to take, the dosage

Iodantinopyrin tablets are taken orally after meals.
Prevention and treatment of tick-borne encephalitis. Treatment:
About 300 mg (3 tablets) – 3 times a day for the first 2 days; 200 mg (2 tablets) – 3 times a day for the next 2 days; 100 mg (1 tablet) – 3 times a day for the next 5 days.
Prevention:

Treatment of hemorrhagic fever with renal syndrome (HFRS).
The drug should be given within five days of onset.
200 mg (2 tablets) 3 times daily for the first four days;
100 mg (1 tablet) 3 times daily for the next five days.

Interaction

Special Instructions

Synopsis

Contraindications

Side effects